DXCM Nicholas Augustinos sells $304K worth of shares
Jun 18, 2025, 4:33 AM
0.00%
What does DXCM do
DexCom, headquartered in San Diego, develops glucose monitoring systems for diabetes management, employing 9,600 people since its IPO in 2005. Its products include the Dexcom G6 and G7 continuous glucose monitoring systems.
Nicholas Augustinos sold 3,672 shares of DXCM on 16 June at $82.80 per share, worth a total of $304K. They now own 33,411 DXCM shares, or a 10% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
